- Research Article
1
- 10.1016/j.annonc.2025.05.337
322P Ivosidenib in pretreated Japanese (JPN) patients (pts) with mutant isocitrate dehydrogenase 1 (mIDH1) nonresectable/metastatic cholangiocarcinoma (n/mCCA): Phase II study results
- Jul 01, 2025
- Annals of Oncology
- T Satake + 9 more +9